Search results for “Maitansine” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 243 patents, we discovered top 36 key players by total patent application. ImmunoGen, Inc., Regeneron Pharmaceuticals, Inc., R.P. Scherer Technologies LLC are dominant in this area. They take 48.97% of the total patent filing.
ImmunoGen, Inc.
Massachusetts, United States
Patent: 73
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 27
R.P. Scherer Technologies LLC
Nevada, United States
Patent: 19
Genentech, Inc.
California, United States
Patent: 18
Sanofi SA
France
Patent: 13
Bayer Intellectual Property GmbH
Nordrhein-Westfalen, Germany
Patent: 11
MacroGenics, Inc.
United States
Patent: 8
Redwood Bioscience, Inc.
California, United States
Patent: 7
Bristol-Myers Squibb FCT bêta, Inc.
Canada
Patent: 7
PolyTherics Ltd.
United Kingdom
Patent: 6
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 3 patents, we discovered top 2 start-ups by total patent application.
STARTUP
SynAffix BV
Noord-Brabant, Netherlands
Patent: 2
STARTUP
Angiex, Inc.
Massachusetts, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 106 patents applied in the last 5 years. We discover 31 most active companies in this area. The fast-growing ImmunoGen, Inc., R.P. Scherer Technologies LLC, MacroGenics, Inc. take 38.68% of patent filing during this period.
ImmunoGen, Inc.
Massachusetts, United States
Patent: 18
R.P. Scherer Technologies LLC
Nevada, United States
Patent: 15
MacroGenics, Inc.
United States
Patent: 8
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 6
Indena SpA
Lombardia, Italy
Patent: 3
Centurion BioPharma Corp.
Delaware, United States
Patent: 3
Bristol-Myers Squibb FCT bêta, Inc.
Canada
Patent: 3
Triphase Accelerator U.S. Corp.
California, United States
Patent: 3
Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Shi, China
Patent: 3
Bio-Thera Solutions, Ltd.
Guangdong Sheng, China
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 106 patents in last 5 years, we discover 23 new entrants. MacroGenics, Inc., Indena SpA, Triphase Accelerator U.S. Corp. are the most active new entrants in this area.
MacroGenics, Inc.
United States
Patent: 8
Indena SpA
Lombardia, Italy
Patent: 3
Triphase Accelerator U.S. Corp.
California, United States
Patent: 3
Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Shi, China
Patent: 3
Triphase Research and Development III Corp.
undefined undefined
Patent: 3
Centurion BioPharma Corp.
Delaware, United States
Patent: 3
STARTUP
SynAffix BV
Noord-Brabant, Netherlands
Patent: 2
Yantai University
Shandong Sheng, China
Patent: 2
Yantai Institute of Materia Medica
undefined undefined
Patent: 1
MabPlex International Co., Ltd.
Shandong Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 9 patents, we discovered top 7 universities and scientific research institutions by total patent application. Yantai University, Shandong University, Fudan University are dominant in this area. They take 44.44% of the total patent filing.
Yantai University
Shandong Sheng, China
Patent: 2
Shandong University
Shandong Sheng, China
Patent: 1
Fudan University
Shanghai Shi, China
Patent: 1
Zhejiang University
Zhejiang Sheng, China
Patent: 1
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 1
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 1
Soochow University
Jiangsu Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: